Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
25(OH)D Level
10%
25-hydroxyvitamin D (25OHD)
11%
25-hydroxyvitamin D Levels
9%
Accelerating Medicines Partnership
16%
American College of Rheumatology
14%
Autoantibodies
10%
Autoimmune Disease
7%
Blood Levels
6%
Cardiovascular Events
6%
Clinically Indicated
7%
Complete Response
5%
COVID-19
9%
End-stage Kidney Disease
10%
Epitope
9%
Estimated Glomerular Filtration Rate
10%
Fibrosis
14%
Granzyme B
5%
Healthy Controls
6%
Histopathological Features
9%
Historical Perspective
9%
Hydroxychloroquine
5%
Immune Landscape
9%
Immunology
9%
Immunomodulatory Drugs (IMiDs)
6%
Inflammation
12%
Interferon-α (IFN-α)
7%
Intrarenal
7%
Keratinocytes
9%
Kidney
12%
Kidney Biopsy
11%
Loss Rate
6%
Lupus
27%
Lupus Nephritis
100%
Meta-analysis
9%
Pericarditis
9%
Prednisone
7%
Proteinuria
13%
Raynaud's Phenomenon
10%
Renal Biopsy
5%
Rheumatoid Arthritis
5%
Scleroderma
9%
Secondary Raynaud's Phenomenon
5%
Single-cell Transcriptomics
14%
Standard-of-care Therapy
5%
Systemic Lupus Erythematosus
55%
Systemic Sclerosis
7%
Treatment Response
9%
Tubular Cells
9%
Urine Protein-to-creatinine Ratio
8%
Urine Proteome
10%
Immunology and Microbiology
Autoantibodies
10%
Autoimmune Disease
8%
Autoimmunity
6%
B Cell
5%
Belimumab
6%
Blood Level
6%
Cell Population
5%
Connective Tissue
5%
COVID-19
6%
Glomerulus Filtration
5%
Hydroxychloroquine
5%
Immune Response
5%
Immunocompetent Cell
5%
Immunosuppressant
6%
Infection
7%
Infectious Disease
7%
Inflammation
8%
Inflammatory Arthritis
5%
interferon
8%
Interleukin 16
5%
Lung
15%
Lupus Erythematosus
73%
Monocyte
8%
Myeloid
6%
Nephritis
61%
Neutrophil
5%
Pericarditis
9%
Prednisone
8%
Proteomics
21%
Raynaud Phenomenon
9%
Scleroderma
15%
Systemic Lupus Erythematosus
59%
Systemic Scleroderma
15%
T Cell
12%
T-Helper Cell
10%
Transcriptomics
6%
Medicine and Dentistry
Belimumab
5%
Biological Marker
10%
Biopsy Technique
11%
Creatinine
12%
Diseases
13%
End Stage Renal Disease
10%
Fibrosis
14%
Flow Cytometry
6%
Glomerular Filtration Rate
11%
Histopathology
5%
Immunocompetent Cell
5%
Immunology
9%
Inflammation
7%
Interferon Type I
5%
Interstitial Lung Disease
8%
Keratinocyte
9%
Kidney Function
9%
Kidney Injury
7%
Lupus Erythematosus
25%
Lupus Nephritis
78%
Prednisone
7%
Proteinuria
13%
Proteomics
10%
Quality of Life
5%
Raynaud Phenomenon
14%
Renal Biopsy
13%
Rheumatology
19%
Scleroderma
6%
Systematic Review
6%
Systemic Lupus Erythematosus
34%
Systemic Scleroderma
11%
T-Helper Cell
5%
Transcriptomics
10%
Treatment Response
10%
